Archer Materials Raises $7 Million to Advance Sovereign Quantum Computing

Capital Raising Fuels Sovereign Quantum Ambitions

Archer Materials (ASX:AXE) has successfully secured $7 million through a two-tranche placement, complemented by a $3 million Share Purchase Plan (SPP), to accelerate its push towards establishing sovereign quantum computing capability in Australia. The capital raise comes hot on the heels of Archer’s strategic agreement with IonQ, a global quantum computing leader, providing the company access to IonQ’s cutting-edge Quantum Cloud platform.

The placement, priced at $0.27 per share, attracted strong support from new institutional investors alongside commitments from Archer’s directors and management, who are collectively investing approximately $140,000, pending shareholder approval. Participants in both the placement and SPP will have the opportunity to receive attaching options exercisable at $0.35, expiring in 2029, also subject to approval at an Extraordinary General Meeting expected in mid-August.

Strategic Partnership with IonQ Unlocks Quantum Cloud Access

Under the three-year partnership, Archer gains guaranteed cloud access to IonQ’s Forte and upcoming Tempo-class quantum systems, enabling the development of proprietary quantum algorithms and applications. This collaboration is a cornerstone of Archer’s strategy to become Australia’s natural owner-operator of sovereign quantum infrastructure, with plans to deploy IonQ hardware on Australian soil in the medium term.

The deal includes advisory services and a joint assessment of Australian data-centre suitability, positioning Archer to build local quantum IP and skills essential for national security and commercial applications. IonQ’s proven track record includes deployments of sovereign quantum systems in Switzerland and South Korea, offering a tested blueprint for Archer’s ambitions.

Funding Allocation and Growth Initiatives

Proceeds from the placement and SPP will primarily fund quantum program development, including IonQ client and project development, quantum machine learning (QML), and qubit advancement. Additionally, funds will support Archer’s biochip and advanced materials technology programs, which target medical diagnostics innovations such as lab-on-a-chip biosensors.

Archer’s CEO, Dr Simon Ruffell, emphasised the capital raising as a strong endorsement of the company’s quantum strategy, stating it provides the financial foundation to execute the IonQ agreement and progress other projects. With over 40 patents filed globally and partnerships with institutions like CSIRO, Archer is positioning itself as Australia’s sole pure-play quantum technology company listed on the ASX.

Share Purchase Plan Opens to Eligible Shareholders

The SPP, offered at the same $0.27 price as the placement, invites eligible shareholders in Australia and New Zealand to apply for up to $30,000 worth of new shares, aiming to raise up to $3 million. Archer retains discretion to accept oversubscriptions or scale back applications, with the plan closing on 3 August 2026.

Shares issued under the placement and SPP will rank equally with existing shares, maintaining shareholder equity balance. Bell Potter Securities acted as sole lead manager and bookrunner, with legal advice from Piper Alderman.

Risks and Next Steps

While the capital raise and partnership mark significant milestones, Archer remains reliant on continued funding and successful commercialisation of its technologies. The company’s quantum and biochip projects are still in the R&D phase, with no revenues yet generated. Regulatory hurdles, market adoption, and key personnel retention present ongoing challenges.

Shareholders will watch closely as Archer moves towards deploying sovereign quantum infrastructure and advancing its biochip prototypes, with the upcoming EGM in August a key event to approve director participation and attaching options. The collaboration with IonQ, combined with Archer’s in-house IP and partnerships, sets a foundation, but the path to commercial quantum computing remains complex and uncertain.